“the EARLY TREATMENT WITH BAMLANIVIMAB ALONE DOES NOT PREVENT COVID-19 HOSPITALIZATION AND ITS POST-ACUTE SEQUELAE. A REAL EXPERIENCE IN UMBRIA, ITALY”., Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021061, Oct. 2021, doi: 10.4084/MJHID.2021.061.